ask="2.30"
ask_size="8000"
average_daily_volume="305834"
bid="1.25"
bid_size="400"
book_value="0.88"
change="-0.05"
change_from_200_day_moving_average="-1.43"
change_from_50_day_moving_average="-0.11"
change_from_52_week_high="-4.88"
change_From_52_week_low="0.27"
change_in_percent="-2.38%"
close="2.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.04"
ex_dividend_date="N/A"
float_shares="28175000"
high="2.14"
high_52_weeks="6.93"
last_trade_date="2/22/2017"
last_trade_price="2.05"
last_trade_size="912"
last_trade_time="4:00pm"
low="2.05"
low_52_weeks="1.77"
market_capitalization="62.76M"
moving_average_200_day="3.48"
moving_average_50_day="2.16"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="2.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-41.04%"
percent_change_from_50_day_moving_average="-5.21%"
percent_change_from_52_week_high="-70.42%"
percent_change_from_52_week_low="+15.49%"
previous_close="2.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.40"
price_per_sales="163.94"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="10.94"
stock_exchange="NCM"
symbol="TROV"
volume="148785"
weeks_range_52="1.77 - 6.93"
